Defective Aire-Dependent Central Tolerance to P0 Is Linked to Autoimmune Peripheral Neuropathy

Chronic Inflammatory Demyelinating Polyneuropathy is a debilitating autoimmune disease characterized by peripheral nerve demyelination and dysfunction. How the autoimmune response is initiated, identity of provoking antigens, and pathogenic effector mechanisms are not well-defined. The Autoimmune Regulator (Aire) plays a critical role in central tolerance by promoting thymic expression of self-antigens and deletion of self-reactive T cells. Here, we utilized mice with hypomorphicAire function and two patients with Aire mutations to define how Aire deficiency results in spontaneous autoimmune peripheral neuropathy. Autoimmunity against peripheral nerves in both mice and humans targets Myelin Protein Zero (P0), an antigen whose expression is Aire-regulated in the thymus. Consistent with a defect in thymic tolerance, CD4+ T cells are sufficient to transfer disease in mice and produce IFN-gamma in infiltrated peripheral nerves. Our findings suggest that defective Aire-mediated central tolerance to P0 initiates an autoimmune Th1 effector response toward peripheral nerves. in part because of the scarcity of robust animal models. We recently reported that spontaneous autoimmune peripheral neuropathy develops in NOD mice harboring a G228W point mutation in the Autoimmune Regulator (Aire) gene (NOD.Aire GW/+ mice) (2). Aire plays a critical role in central tolerance by upregulating the ectopic expression of a wide array of tissue-specific self-antigens in medullary thymic epithelial cells (mTECs) (3) and promoting the negative selection of developing thymocytes that recognize these antigens with high affinity (4). NOD.Aire GW/+ mice have hypomorphicAire function in that mTECs

[1]  D. Geschwind,et al.  Specific Functions for ERK/MAPK Signaling during PNS Development , 2011, Neuron.

[2]  J. Ting,et al.  Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle , 2010, Journal of neuroscience research.

[3]  Mark S. Anderson,et al.  Identification of an Autoantigen Demonstrates a Link Between Interstitial Lung Disease and a Defect in Central Tolerance , 2009, Science Translational Medicine.

[4]  J. Vallat,et al.  Evidence-Based Treatment Of Chronic Immune-Mediated Neuropathies , 2009, Expert opinion on pharmacotherapy.

[5]  L. Melton,et al.  Incidence and prevalence of CIDP and the association of diabetes mellitus , 2009, Neurology.

[6]  Mark S. Anderson,et al.  A novel myelin P0–specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy , 2009, The Journal of experimental medicine.

[7]  B. Giometto,et al.  Chronic inflammatory demyelinating polyneuropathy as a possible novel component of autoimmune poly-endocrine-candidiasis-ectodermal dystrophy , 2009, European Journal of Pediatrics.

[8]  M. Jensen,et al.  Targeting of Myelin Protein Zero in a Spontaneous Autoimmune Polyneuropathy1 , 2008, The Journal of Immunology.

[9]  Howard Y. Chang,et al.  Mechanisms of an autoimmunity syndrome in mice caused by a dominant mutation in Aire. , 2008, The Journal of clinical investigation.

[10]  S. Miller,et al.  Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease , 2007, Nature Reviews Immunology.

[11]  Mark S. Anderson,et al.  Spontaneous autoimmunity prevented by thymic expression of a single self-antigen , 2006, The Journal of experimental medicine.

[12]  M. Pender,et al.  T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  Mark S. Anderson,et al.  The cellular mechanism of Aire control of T cell tolerance. , 2005, Immunity.

[14]  R. Hughes,et al.  Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy , 2005 .

[15]  B. Soliven,et al.  Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. , 2004, Frontiers in bioscience : a journal and virtual library.

[16]  Mark S. Anderson,et al.  Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein , 2002, Science.

[17]  H. Hartung,et al.  Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. , 2002, Brain : a journal of neurology.

[18]  A. Montag,et al.  Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice , 2001, The Journal of experimental medicine.

[19]  B. Winblad,et al.  P0 protein peptide 180‐199 together with pertussis toxin induces experimental autoimmune neuritis in resistant C57BL/6 mice , 2000, Journal of neuroscience research.

[20]  R. Martini Animal models for inherited peripheral neuropathies , 2000, Journal of neuroscience research.

[21]  F. Chédru,et al.  Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy , 1999, Neurology.

[22]  H. Lassmann,et al.  Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. , 1992, European journal of immunology.

[23]  J. McArthur,et al.  Quantitative analysis of endoneurial T-cells in human sural nerve biopsies , 1990, Journal of Neuroimmunology.